Nu-Med Plus (NUMD) Payables (2012 - 2025)

Nu-Med Plus (NUMD) reported Payables of $148203.0 for Q4 2025, up 3.61% on a YoY basis from $143040.0 in Q4 2024, and little changed sequentially from $147847.0 in Q3 2025.

Nu-Med Plus (NUMD) Payables (2012 - 2025) Analysis & Trends

Nu-Med Plus (NUMD) has 14 years of Payables data on file, last reported at $148203.0 in Q4 2025.

  • For the quarter ending Q4 2025, Payables rose 3.61% year-over-year to $148203.0; the trailing twelve-month figure through Dec 2025 stood at $148203.0 (up 3.61% YoY), and the FY2025 full-year result was $148203.0, up 3.61% from the prior year.
  • Payables steadied at $148203.0 in Q4 2025, from $147847.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $155204.0 in Q2 2025 to a low of $32744.0 in Q2 2021.
  • A 5-year average of $105728.8 and a median of $113963.0 in 2023 frame the typical range for Payables.
  • Across the five-year window, Payables plunged 85.19% in 2021 and surged 263.15% in 2022, its largest moves.
  • Tracing NUMD's Payables over 5 years: stood at $53744.0 in 2021, then soared by 99.45% to $107192.0 in 2022, then dropped by 6.26% to $100478.0 in 2023, then surged by 42.36% to $143040.0 in 2024, then grew by 3.61% to $148203.0 in 2025.
  • Business Quant data shows NUMD's Payables at $148203.0 in Q4 2025, $147847.0 in Q3 2025, and $155204.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 184.10 Bn 176.81 Bn 6.27 Bn 5.78 Bn
2 Stryker 128.79 Bn 125.91 Bn 3.81 Bn 1.93 Bn
3 Medtronic 108.97 Bn 99.75 Bn 6.41 Bn 2.64 Bn
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn 181.10 Mn
6 GE HealthCare Technologies 28.40 Bn 26.11 Bn 1.98 Bn 3.42 Bn
7 Dexcom 28.32 Bn 27.20 Bn 750.30 Mn -
8 Smith & Nephew 26.94 Bn 26.36 Bn - 1.18 Bn
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn 2.39 Bn
10 Nu-Med Plus 1.67 Mn 1.67 Mn - 148,203.00

Historic Data

Download Data
DateValue
Dec 31, 2025 148,203.00
Sep 30, 2025 147,847.00
Jun 30, 2025 155,204.00
Mar 31, 2025 142,995.00
Dec 31, 2024 143,040.00
Sep 30, 2024 119,850.00
Jun 30, 2024 109,225.00
Mar 31, 2024 116,457.00
Dec 31, 2023 100,478.00
Sep 30, 2023 106,585.00
Jun 30, 2023 114,239.00
Mar 31, 2023 113,687.00
Dec 31, 2022 107,192.00
Sep 30, 2022 128,744.00
Jun 30, 2022 118,910.00
Mar 31, 2022 78,244.00
Dec 31, 2021 53,744.00
Sep 30, 2021 38,544.00
Jun 30, 2021 32,744.00
Mar 31, 2021 38,645.00